TY - JOUR
T1 - Functional status in older patients with lung cancer
T2 - an observational cohort study
AU - Couderc, Anne Laure
AU - Tomasini, Pascale
AU - Greillier, Laurent
AU - Nouguerède, Emilie
AU - Rey, Dominique
AU - Montegut, Coline
AU - Thomas, Pascal Alexandre
AU - Barlesi, Fabrice
AU - Villani, Patrick
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Purpose: An assessment of the impact of functional status (FS) evaluated using a combination of Activities of Daily Living (ADL) and the short version of the Instrumental Activities of Daily Living (IADL), on 3- and 6- month mortality and on 3-month unplanned hospitalizations in older patients treated for lung cancers. Method and objectives: This observational retrospective study was conducted between September 2015 and January 2019 at Marseille University Hospital (AP-HM). During this period, all consecutive outpatients aged 70 years or older referred for a comprehensive geriatric assessment (CGA) before the initiation of lung cancer treatment were enrolled. Results: Two hundred twenty-seven patients were analyzed: the median age was 78.7 years and 74.0% were male. Almost half of the patients were metastatic (45.4%). Concerning FS, 41.9% of patients had no ADL-IADL impairment, 30.0% had either IADL or ADL impairment, and both ADL-IADL were impaired for 28.1%. Impaired ADL-IADL was associated with poor nutritional status, depression, mobility, and cognitive disorders. In a logistic regression model, ADL or IADL impairment (aOR = 2.1; 95% CI [1.0–4.2]; p = 0.037) and impaired ADL-IADL (aOR = 2.6; 95% CI [1.2–5.3]; p = 0.012) were independently associated with a higher risk of unplanned hospitalizations within 3 months. In the multivariate Cox model, 6-month mortality risk was independently associated with impaired ADL-IADL (aHR = 2.3; 95% CI [1.3–4.4]; p = 0.008). Conclusion: The combination of ADL and IADL scales to assess FS is a prognostic marker of the mortality risk at 6 months in older patients with lung cancer and should be more largely used by oncologists in treatment decision making.
AB - Purpose: An assessment of the impact of functional status (FS) evaluated using a combination of Activities of Daily Living (ADL) and the short version of the Instrumental Activities of Daily Living (IADL), on 3- and 6- month mortality and on 3-month unplanned hospitalizations in older patients treated for lung cancers. Method and objectives: This observational retrospective study was conducted between September 2015 and January 2019 at Marseille University Hospital (AP-HM). During this period, all consecutive outpatients aged 70 years or older referred for a comprehensive geriatric assessment (CGA) before the initiation of lung cancer treatment were enrolled. Results: Two hundred twenty-seven patients were analyzed: the median age was 78.7 years and 74.0% were male. Almost half of the patients were metastatic (45.4%). Concerning FS, 41.9% of patients had no ADL-IADL impairment, 30.0% had either IADL or ADL impairment, and both ADL-IADL were impaired for 28.1%. Impaired ADL-IADL was associated with poor nutritional status, depression, mobility, and cognitive disorders. In a logistic regression model, ADL or IADL impairment (aOR = 2.1; 95% CI [1.0–4.2]; p = 0.037) and impaired ADL-IADL (aOR = 2.6; 95% CI [1.2–5.3]; p = 0.012) were independently associated with a higher risk of unplanned hospitalizations within 3 months. In the multivariate Cox model, 6-month mortality risk was independently associated with impaired ADL-IADL (aHR = 2.3; 95% CI [1.3–4.4]; p = 0.008). Conclusion: The combination of ADL and IADL scales to assess FS is a prognostic marker of the mortality risk at 6 months in older patients with lung cancer and should be more largely used by oncologists in treatment decision making.
KW - Aged
KW - Cancer treatment protocols
KW - Daily living activities
KW - Functional status
KW - Lung cancer
KW - Mortality
UR - http://www.scopus.com/inward/record.url?scp=85123108931&partnerID=8YFLogxK
U2 - 10.1007/s00520-021-06752-2
DO - 10.1007/s00520-021-06752-2
M3 - Article
C2 - 35031829
AN - SCOPUS:85123108931
SN - 0941-4355
VL - 30
SP - 3817
EP - 3827
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 5
ER -